Login
← Go Back
Nectar Lifesciences
NECLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Sanjiv Goyal · MD: Sanjiv Goyal · Listing date: July 19, 2005 · Employees: 1693 · Chandigarh · http://www.neclife.com
Stock Price vs Company Growth
1d
1.1%
1w
1.6%
1m
15.9%
3m
5.2%
6m
8.9%
1y
13.3%
5y
16.0%
10y
10.6%
all
1.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 12.3 1.1%
10
13.4
Company Overview
Sales
7.44 Cr
Growth: -11.8%
Profit after Tax
-280 Cr
Growth: -14.6%
Micro Cap
239 Cr
P/S: 32.0x
Industry P/S: 2.9x
Fundamentals
Sales (Cr) ₹ 7.44
Growth -11.8%
EBITDA N/A
P/S 32.0x
Dividend 0.0%
P/E N/A
Book Value ₹ 1
PEG Ratio N/A
ROE -1337.4%
P/B N/A
Shareholding Pattern
Institutions
Nsr Direct Pe Mauritius Llc
14.59 %
Ingain Traders, Llc
1.34 %
Iepf
0.02 %
Promoters
Sanjiv Goyal
31.33 %
Sanjiv (Huf)
24.47 %
Others
Increase    Decrease    No change
Company Profile Detailed
Nectar is a global pharmaceutical company specializing in Cephalosporins.
Belongs to (4 Indices)
Investors (30)
religare...
mansi.sh...
f3.advis...
Followers (2)
bhaskar6
sanjayda...